BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1351514 CSC1CC(C)NC(=O)C1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)N1CC(C1)N(C)C |r,wU:29.35,wD:26.28,(-6.29,-22.26,;-6.29,-20.72,;-7.62,-19.95,;-8.96,-20.72,;-10.29,-19.95,;-11.62,-20.72,;-10.29,-18.41,;-8.96,-17.64,;-8.96,-16.1,;-7.62,-18.41,;-6.29,-17.64,;-4.95,-18.41,;-3.62,-17.64,;-3.62,-16.1,;-2.29,-18.41,;-2.29,-19.95,;-.95,-20.72,;-.95,-22.26,;.38,-19.95,;1.85,-20.43,;2.75,-19.18,;3.84,-20.27,;1.85,-17.94,;.38,-18.41,;-.95,-17.64,;-.95,-16.1,;4.08,-18.41,;5.42,-19.18,;6.75,-18.41,;6.75,-16.87,;5.42,-16.1,;4.08,-16.87,;8.09,-16.1,;9.57,-16.5,;9.97,-15.02,;8.48,-14.62,;11.31,-14.25,;12.64,-15.02,;11.31,-12.71,)| InChI=1S/C29H43ClN4O4S/c1-16-11-24(39-6)22(28(36)32-16)13-31-27(35)21-12-23(30)26-25(17(21)2)37-29(3,38-26)18-7-9-19(10-8-18)34-14-20(15-34)33(4)5/h12,16,18-20,22,24H,7-11,13-15H2,1-6H3,(H,31,35)(H,32,36) WKEAXHOQKPDGQP-UHFFFAOYSA-N 636152 US20230365541, Compound 1, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.670 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636152 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636152&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551802 486501796 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351515 CSC1CC(C)NC(=O)C1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)N1CC(C1)N(C)C |r,wU:26.28,29.35,(-6.29,-22.26,;-6.29,-20.72,;-7.62,-19.95,;-8.96,-20.72,;-10.29,-19.95,;-11.62,-20.72,;-10.29,-18.41,;-8.96,-17.64,;-8.96,-16.1,;-7.62,-18.41,;-6.29,-17.64,;-4.95,-18.41,;-3.62,-17.64,;-3.62,-16.1,;-2.29,-18.41,;-2.29,-19.95,;-.95,-20.72,;-.95,-22.26,;.38,-19.95,;1.85,-20.43,;2.75,-19.18,;3.84,-20.27,;1.85,-17.94,;.38,-18.41,;-.95,-17.64,;-.95,-16.1,;4.08,-18.41,;5.42,-19.18,;6.75,-18.41,;6.75,-16.87,;5.42,-16.1,;4.08,-16.87,;8.09,-16.1,;9.57,-16.5,;9.97,-15.02,;8.48,-14.62,;11.31,-14.25,;12.64,-15.02,;11.31,-12.71,)| InChI=1S/C29H43ClN4O4S/c1-16-11-24(39-6)22(28(36)32-16)13-31-27(35)21-12-23(30)26-25(17(21)2)37-29(3,38-26)18-7-9-19(10-8-18)34-14-20(15-34)33(4)5/h12,16,18-20,22,24H,7-11,13-15H2,1-6H3,(H,31,35)(H,32,36) WKEAXHOQKPDGQP-UHFFFAOYSA-N 636153 US20230365541, Compound 1, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.600 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636153 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636153&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551802 486501797 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351516 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)N1CC(C1)C#N |r,wU:29.35,wD:26.28,(6.8,-28.32,;6.8,-26.78,;5.47,-26.01,;4.13,-26.78,;2.8,-26.01,;1.46,-26.78,;2.8,-24.47,;4.13,-23.7,;4.13,-22.16,;5.47,-24.47,;6.8,-23.7,;8.13,-24.47,;9.47,-23.7,;9.47,-22.16,;10.8,-24.47,;10.8,-26.01,;12.13,-26.78,;12.13,-28.32,;13.47,-26.01,;14.93,-26.48,;15.84,-25.24,;16.93,-26.32,;14.93,-23.99,;13.47,-24.47,;12.13,-23.7,;12.13,-22.16,;17.17,-24.47,;18.51,-25.24,;19.84,-24.47,;19.84,-22.93,;18.51,-22.16,;17.17,-22.93,;21.17,-22.16,;22.66,-22.55,;23.41,-20.86,;21.57,-20.67,;24.99,-19.95,;26.57,-19.04,)| InChI=1S/C28H33ClN4O4S/c1-15-9-23(38-4)21(27(35)32-15)12-31-26(34)20-10-22(29)25-24(16(20)2)36-28(3,37-25)18-5-7-19(8-6-18)33-13-17(11-30)14-33/h9-10,17-19H,5-8,12-14H2,1-4H3,(H,31,34)(H,32,35) WZQVSACWDSGBOB-UHFFFAOYSA-N 636154 US20230365541, Compound 2, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.920 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636154 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636154&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551803 486501798 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351517 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)N1CC(C1)C#N |r,wU:26.28,29.35,(6.8,-28.32,;6.8,-26.78,;5.47,-26.01,;4.13,-26.78,;2.8,-26.01,;1.46,-26.78,;2.8,-24.47,;4.13,-23.7,;4.13,-22.16,;5.47,-24.47,;6.8,-23.7,;8.13,-24.47,;9.47,-23.7,;9.47,-22.16,;10.8,-24.47,;10.8,-26.01,;12.13,-26.78,;12.13,-28.32,;13.47,-26.01,;14.93,-26.48,;15.84,-25.24,;16.93,-26.32,;14.93,-23.99,;13.47,-24.47,;12.13,-23.7,;12.13,-22.16,;17.17,-24.47,;18.51,-25.24,;19.84,-24.47,;19.84,-22.93,;18.51,-22.16,;17.17,-22.93,;21.17,-22.16,;22.66,-22.55,;23.41,-20.86,;21.57,-20.67,;24.99,-19.95,;26.57,-19.04,)| InChI=1S/C28H33ClN4O4S/c1-15-9-23(38-4)21(27(35)32-15)12-31-26(34)20-10-22(29)25-24(16(20)2)36-28(3,37-25)18-5-7-19(8-6-18)33-13-17(11-30)14-33/h9-10,17-19H,5-8,12-14H2,1-4H3,(H,31,34)(H,32,35) WZQVSACWDSGBOB-UHFFFAOYSA-N 636155 US20230365541, Compound 2, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.720 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636155 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636155&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551803 486501799 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351518 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)NCC1(C)COC1 |r,wU:26.28,29.35,(6.67,-27.07,;6.67,-25.53,;5.34,-24.76,;4,-25.53,;2.67,-24.76,;1.33,-25.53,;2.67,-23.22,;4,-22.45,;4,-20.91,;5.34,-23.22,;6.67,-22.45,;8,-23.22,;9.34,-22.45,;9.34,-20.91,;10.67,-23.22,;10.67,-24.76,;12,-25.53,;12,-27.07,;13.34,-24.76,;14.8,-25.24,;15.71,-23.99,;16.8,-25.08,;14.8,-22.74,;13.34,-23.22,;12,-22.45,;12,-20.91,;17.04,-23.22,;18.37,-23.99,;19.71,-23.22,;19.71,-21.68,;18.37,-20.91,;17.04,-21.68,;21.04,-20.91,;22.38,-21.68,;23.71,-20.91,;22.38,-20.14,;24.8,-22,;25.89,-20.91,;24.8,-19.82,)| InChI=1S/C29H38ClN3O5S/c1-16-10-23(39-5)21(27(35)33-16)12-31-26(34)20-11-22(30)25-24(17(20)2)37-29(4,38-25)18-6-8-19(9-7-18)32-13-28(3)14-36-15-28/h10-11,18-19,32H,6-9,12-15H2,1-5H3,(H,31,34)(H,33,35) ZHMRARCDOBQZEP-UHFFFAOYSA-N 636156 US20230365541, Compound 3, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.650 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636156 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636156&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551804 486501800 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351519 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)NCC1(C)COC1 |r,wU:29.35,wD:26.28,(6.67,-27.07,;6.67,-25.53,;5.34,-24.76,;4,-25.53,;2.67,-24.76,;1.33,-25.53,;2.67,-23.22,;4,-22.45,;4,-20.91,;5.34,-23.22,;6.67,-22.45,;8,-23.22,;9.34,-22.45,;9.34,-20.91,;10.67,-23.22,;10.67,-24.76,;12,-25.53,;12,-27.07,;13.34,-24.76,;14.8,-25.24,;15.71,-23.99,;16.8,-25.08,;14.8,-22.74,;13.34,-23.22,;12,-22.45,;12,-20.91,;17.04,-23.22,;18.37,-23.99,;19.71,-23.22,;19.71,-21.68,;18.37,-20.91,;17.04,-21.68,;21.04,-20.91,;22.38,-21.68,;23.71,-20.91,;22.38,-20.14,;24.8,-22,;25.89,-20.91,;24.8,-19.82,)| InChI=1S/C29H38ClN3O5S/c1-16-10-23(39-5)21(27(35)33-16)12-31-26(34)20-11-22(30)25-24(17(20)2)37-29(4,38-25)18-6-8-19(9-7-18)32-13-28(3)14-36-15-28/h10-11,18-19,32H,6-9,12-15H2,1-5H3,(H,31,34)(H,33,35) ZHMRARCDOBQZEP-UHFFFAOYSA-N 636157 US20230365541, Compound 3, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.510 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636157&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551804 486501801 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351520 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)NC1CC(F)(F)C1 |r,wU:26.28,wD:29.35,(6.57,-23.57,;6.57,-22.03,;5.23,-21.26,;3.9,-22.03,;2.56,-21.26,;1.23,-22.03,;2.56,-19.72,;3.9,-18.95,;3.9,-17.41,;5.23,-19.72,;6.57,-18.95,;7.9,-19.72,;9.23,-18.95,;9.23,-17.41,;10.57,-19.72,;10.57,-21.26,;11.9,-22.03,;11.9,-23.57,;13.23,-21.26,;14.7,-21.73,;15.6,-20.49,;16.69,-21.58,;14.7,-19.24,;13.23,-19.72,;11.9,-18.95,;11.9,-17.41,;16.94,-19.72,;16.94,-18.18,;18.27,-17.41,;19.6,-18.18,;19.6,-19.72,;18.27,-20.49,;20.94,-17.41,;22.27,-18.18,;22.67,-19.67,;24.16,-19.27,;25.7,-19.27,;24.93,-20.6,;23.76,-17.78,)| InChI=1S/C28H34ClF2N3O4S/c1-14-9-22(39-4)20(26(36)33-14)13-32-25(35)19-10-21(29)24-23(15(19)2)37-27(3,38-24)16-5-7-17(8-6-16)34-18-11-28(30,31)12-18/h9-10,16-18,34H,5-8,11-13H2,1-4H3,(H,32,35)(H,33,36) VXEJHUGGAMXCBU-UHFFFAOYSA-N 636158 US20230365541, Compound 4, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.460 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636158 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636158&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551805 486501802 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351521 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)NC1CC(F)(F)C1 |r,wD:26.28,29.35,(6.56,-23.56,;6.56,-22.02,;5.23,-21.25,;3.89,-22.02,;2.56,-21.25,;1.23,-22.02,;2.56,-19.71,;3.89,-18.94,;3.89,-17.4,;5.23,-19.71,;6.56,-18.94,;7.9,-19.71,;9.23,-18.94,;9.23,-17.4,;10.56,-19.71,;10.56,-21.25,;11.9,-22.02,;11.9,-23.56,;13.23,-21.25,;14.69,-21.73,;15.6,-20.48,;16.69,-21.57,;14.69,-19.24,;13.23,-19.71,;11.9,-18.94,;11.9,-17.4,;16.93,-19.71,;16.93,-18.17,;18.27,-17.4,;19.6,-18.17,;19.6,-19.71,;18.27,-20.48,;20.93,-17.4,;22.27,-18.17,;22.67,-19.66,;24.15,-19.26,;25.69,-19.26,;24.92,-20.6,;23.76,-17.78,)| InChI=1S/C28H34ClF2N3O4S/c1-14-9-22(39-4)20(26(36)33-14)13-32-25(35)19-10-21(29)24-23(15(19)2)37-27(3,38-24)16-5-7-17(8-6-16)34-18-11-28(30,31)12-18/h9-10,16-18,34H,5-8,11-13H2,1-4H3,(H,32,35)(H,33,36) VXEJHUGGAMXCBU-UHFFFAOYSA-N 636159 US20230365541, Compound 4, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.560 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636159 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636159&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551805 486501803 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351522 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2O[C@](C)(Oc2c1C)C1CCN(CC1)C(=O)C1CC(F)(F)C1 |r| InChI=1S/C28H32ClF2N3O5S/c1-14-9-21(40-4)19(25(36)33-14)13-32-24(35)18-10-20(29)23-22(15(18)2)38-27(3,39-23)17-5-7-34(8-6-17)26(37)16-11-28(30,31)12-16/h9-10,16-17H,5-8,11-13H2,1-4H3,(H,32,35)(H,33,36) QAQOBRBOKYIWIG-UHFFFAOYSA-N 636160 US20230365541, Compound 5, isomer 1::US20230365541, Compound 10, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.580 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636160&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551806 486501804 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351523 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)NC(=O)C1CC(F)(F)C1 |r,wD:26.28,29.35,(6.39,-31.25,;6.39,-29.71,;5.06,-28.94,;3.73,-29.71,;2.39,-28.94,;1.06,-29.71,;2.39,-27.4,;3.73,-26.63,;3.73,-25.09,;5.06,-27.4,;6.39,-26.63,;7.73,-27.4,;9.06,-26.63,;9.06,-25.09,;10.4,-27.4,;10.4,-28.94,;11.73,-29.71,;11.73,-31.25,;13.06,-28.94,;14.53,-29.42,;15.43,-28.17,;16.52,-29.26,;14.53,-26.93,;13.06,-27.4,;11.73,-26.63,;11.73,-25.09,;16.77,-27.4,;16.77,-25.86,;18.1,-25.09,;19.43,-25.86,;19.43,-27.4,;18.1,-28.17,;20.77,-25.09,;22.1,-25.86,;22.1,-27.4,;23.43,-25.09,;24.92,-25.49,;25.32,-24,;26.86,-24,;26.09,-22.67,;23.83,-23.61,)| InChI=1S/C29H34ClF2N3O5S/c1-14-9-22(41-4)20(27(38)34-14)13-33-26(37)19-10-21(30)24-23(15(19)2)39-28(3,40-24)17-5-7-18(8-6-17)35-25(36)16-11-29(31,32)12-16/h9-10,16-18H,5-8,11-13H2,1-4H3,(H,33,37)(H,34,38)(H,35,36) UIEWFELNVUIXER-UHFFFAOYSA-N 636161 US20230365541, Compound 6, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.520 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636161 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636161&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551807 486501805 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351524 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)NC(=O)C1CC(F)(F)C1 |r,wU:26.28,wD:29.35,(6.39,-31.25,;6.39,-29.71,;5.06,-28.94,;3.73,-29.71,;2.39,-28.94,;1.06,-29.71,;2.39,-27.4,;3.73,-26.63,;3.73,-25.09,;5.06,-27.4,;6.39,-26.63,;7.73,-27.4,;9.06,-26.63,;9.06,-25.09,;10.4,-27.4,;10.4,-28.94,;11.73,-29.71,;11.73,-31.25,;13.06,-28.94,;14.53,-29.42,;15.43,-28.17,;16.52,-29.26,;14.53,-26.93,;13.06,-27.4,;11.73,-26.63,;11.73,-25.09,;16.77,-27.4,;16.77,-25.86,;18.1,-25.09,;19.43,-25.86,;19.43,-27.4,;18.1,-28.17,;20.77,-25.09,;22.1,-25.86,;22.1,-27.4,;23.43,-25.09,;24.92,-25.49,;25.32,-24,;26.86,-24,;26.09,-22.67,;23.83,-23.61,)| InChI=1S/C29H34ClF2N3O5S/c1-14-9-22(41-4)20(27(38)34-14)13-33-26(37)19-10-21(30)24-23(15(19)2)39-28(3,40-24)17-5-7-18(8-6-17)35-25(36)16-11-29(31,32)12-16/h9-10,16-18H,5-8,11-13H2,1-4H3,(H,33,37)(H,34,38)(H,35,36) UIEWFELNVUIXER-UHFFFAOYSA-N 636162 US20230365541, Compound 6, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.640 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636162 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636162&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551807 486501806 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351525 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2O[C@@](C)(Oc2c1C)C1CCN(CC1)C(=O)C1CC1 |r| InChI=1S/C27H32ClN3O5S/c1-14-11-21(37-4)19(25(33)30-14)13-29-24(32)18-12-20(28)23-22(15(18)2)35-27(3,36-23)17-7-9-31(10-8-17)26(34)16-5-6-16/h11-12,16-17H,5-10,13H2,1-4H3,(H,29,32)(H,30,33) DKBJHQQCVQYPDJ-UHFFFAOYSA-N 636163 US20230365541, Compound 7, isomer 1::US20230365541, Compound 11, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.520 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636163 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636163&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551808 486501807 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351526 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CCC(CC1)c1cnn(C)c1 |r,wD:26.28,(7.22,-24.92,;7.22,-23.38,;5.89,-22.61,;4.55,-23.38,;3.22,-22.61,;1.89,-23.38,;3.22,-21.07,;4.55,-20.3,;4.55,-18.76,;5.89,-21.07,;7.22,-20.3,;8.56,-21.07,;9.89,-20.3,;9.89,-18.76,;11.22,-21.07,;11.22,-22.61,;12.56,-23.38,;12.56,-24.92,;13.89,-22.61,;15.35,-23.09,;16.26,-21.84,;17.35,-22.93,;15.35,-20.6,;13.89,-21.07,;12.56,-20.3,;12.56,-18.76,;17.59,-21.07,;18.93,-21.84,;20.26,-21.07,;20.26,-19.53,;18.93,-18.76,;17.59,-19.53,;21.59,-18.76,;23,-19.39,;24.03,-18.24,;23.26,-16.91,;23.89,-15.5,;21.76,-17.23,)| InChI=1S/C28H33ClN4O4S/c1-15-10-23(38-5)21(27(35)32-15)13-30-26(34)20-11-22(29)25-24(16(20)2)36-28(3,37-25)19-8-6-17(7-9-19)18-12-31-33(4)14-18/h10-12,14,17,19H,6-9,13H2,1-5H3,(H,30,34)(H,32,35) ZXCKPBIOZHSVLT-UHFFFAOYSA-N 636164 US20230365541, Compound 8, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.510 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636164 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636164&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551809 486501808 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351527 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CCC(CC1)c1cnn(C)c1 |r,wU:26.28,(7.22,-24.92,;7.22,-23.38,;5.89,-22.61,;4.55,-23.38,;3.22,-22.61,;1.89,-23.38,;3.22,-21.07,;4.55,-20.3,;4.55,-18.76,;5.89,-21.07,;7.22,-20.3,;8.56,-21.07,;9.89,-20.3,;9.89,-18.76,;11.22,-21.07,;11.22,-22.61,;12.56,-23.38,;12.56,-24.92,;13.89,-22.61,;15.35,-23.09,;16.26,-21.84,;17.35,-22.93,;15.35,-20.6,;13.89,-21.07,;12.56,-20.3,;12.56,-18.76,;17.59,-21.07,;17.59,-19.53,;18.93,-18.76,;20.26,-19.53,;20.26,-21.07,;18.93,-21.84,;21.59,-18.76,;23,-19.39,;24.03,-18.24,;23.26,-16.91,;23.89,-15.5,;21.76,-17.23,)| InChI=1S/C28H33ClN4O4S/c1-15-10-23(38-5)21(27(35)32-15)13-30-26(34)20-11-22(29)25-24(16(20)2)36-28(3,37-25)19-8-6-17(7-9-19)18-12-31-33(4)14-18/h10-12,14,17,19H,6-9,13H2,1-5H3,(H,30,34)(H,32,35) ZXCKPBIOZHSVLT-UHFFFAOYSA-N 636165 US20230365541, Compound 8, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.900 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636165 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636165&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551809 486501809 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351528 CO[C@H]1C[C@@H](C1)N[C@H]1CC[C@@H](CC1)C1(C)Oc2c(O1)c(C)c(cc2Cl)C(=O)NCc1c(SC)cc(C)[nH]c1=O |r,wU:7.7,4.6,wD:10.14,2.1,(-.82,-22.62,;-2.15,-23.39,;-3.49,-22.62,;-3.88,-21.14,;-5.37,-21.54,;-4.97,-23.02,;-6.71,-20.77,;-8.04,-21.54,;-8.04,-23.08,;-9.37,-23.85,;-10.71,-23.08,;-10.71,-21.54,;-9.37,-20.77,;-12.04,-23.85,;-10.95,-24.93,;-12.95,-25.09,;-14.41,-24.62,;-14.41,-23.08,;-12.95,-22.6,;-15.74,-22.31,;-15.74,-20.77,;-17.08,-23.08,;-17.08,-24.62,;-15.74,-25.39,;-15.74,-26.93,;-18.41,-22.31,;-18.41,-20.77,;-19.74,-23.08,;-21.08,-22.31,;-22.41,-23.08,;-22.41,-24.62,;-21.08,-25.39,;-21.08,-26.93,;-23.75,-25.39,;-25.08,-24.62,;-26.41,-25.39,;-25.08,-23.08,;-23.75,-22.31,;-23.75,-20.77,)| InChI=1S/C29H38ClN3O5S/c1-15-10-24(39-5)22(28(35)32-15)14-31-27(34)21-13-23(30)26-25(16(21)2)37-29(3,38-26)17-6-8-18(9-7-17)33-19-11-20(12-19)36-4/h10,13,17-20,33H,6-9,11-12,14H2,1-5H3,(H,31,34)(H,32,35) CIJHVAWUSUTLMM-UHFFFAOYSA-N 636166 US20230365541, Compound 9, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.810 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636166 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636166&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551810 486501810 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351529 CO[C@H]1C[C@@H](C1)N[C@H]1CC[C@H](CC1)C1(C)Oc2c(O1)c(C)c(cc2Cl)C(=O)NCc1c(SC)cc(C)[nH]c1=O |r,wU:10.14,7.7,4.6,wD:2.1,(-.82,-22.62,;-2.15,-23.39,;-3.49,-22.62,;-3.88,-21.14,;-5.37,-21.54,;-4.97,-23.02,;-6.71,-20.77,;-8.04,-21.54,;-8.04,-23.08,;-9.37,-23.85,;-10.71,-23.08,;-10.71,-21.54,;-9.37,-20.77,;-12.04,-23.85,;-10.95,-24.93,;-12.95,-25.09,;-14.41,-24.62,;-14.41,-23.08,;-12.95,-22.6,;-15.74,-22.31,;-15.74,-20.77,;-17.08,-23.08,;-17.08,-24.62,;-15.74,-25.39,;-15.74,-26.93,;-18.41,-22.31,;-18.41,-20.77,;-19.74,-23.08,;-21.08,-22.31,;-22.41,-23.08,;-22.41,-24.62,;-21.08,-25.39,;-21.08,-26.93,;-23.75,-25.39,;-25.08,-24.62,;-26.41,-25.39,;-25.08,-23.08,;-23.75,-22.31,;-23.75,-20.77,)| InChI=1S/C29H38ClN3O5S/c1-15-10-24(39-5)22(28(35)32-15)14-31-27(34)21-13-23(30)26-25(16(21)2)37-29(3,38-26)17-6-8-18(9-7-17)33-19-11-20(12-19)36-4/h10,13,17-20,33H,6-9,11-12,14H2,1-5H3,(H,31,34)(H,32,35) CIJHVAWUSUTLMM-UHFFFAOYSA-N 636167 US20230365541, Compound 9, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.480 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636167 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636167&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551810 486501811 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351530 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2O[C@](C)(Oc2c1C)C1CCN(CC1)C(=O)C1CC(F)(F)C1 |r| InChI=1S/C28H32ClF2N3O5S/c1-14-9-21(40-4)19(25(36)33-14)13-32-24(35)18-10-20(29)23-22(15(18)2)38-27(3,39-23)17-5-7-34(8-6-17)26(37)16-11-28(30,31)12-16/h9-10,16-17H,5-8,11-13H2,1-4H3,(H,32,35)(H,33,36) QAQOBRBOKYIWIG-UHFFFAOYSA-N 636160 US20230365541, Compound 5, isomer 1::US20230365541, Compound 10, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.560 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636160&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551806 486501804 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351531 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2O[C@@](C)(Oc2c1C)C1CCN(CC1)C(=O)C1CC1 |r| InChI=1S/C27H32ClN3O5S/c1-14-11-21(37-4)19(25(33)30-14)13-29-24(32)18-12-20(28)23-22(15(18)2)35-27(3,36-23)17-7-9-31(10-8-17)26(34)16-5-6-16/h11-12,16-17H,5-10,13H2,1-4H3,(H,29,32)(H,30,33) DKBJHQQCVQYPDJ-UHFFFAOYSA-N 636163 US20230365541, Compound 7, isomer 1::US20230365541, Compound 11, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.730 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636163 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636163&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551808 486501807 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351532 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2O[C@](C)(Oc2c1C)C1CCN(CC1)C(=O)C1CC1 |r| InChI=1S/C27H32ClN3O5S/c1-14-11-21(37-4)19(25(33)30-14)13-29-24(32)18-12-20(28)23-22(15(18)2)35-27(3,36-23)17-7-9-31(10-8-17)26(34)16-5-6-16/h11-12,16-17H,5-10,13H2,1-4H3,(H,29,32)(H,30,33) DKBJHQQCVQYPDJ-UHFFFAOYSA-N 636170 US20230365541, Compound 11, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.880 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636170 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636170&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551811 486501812 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351533 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2O[C@@](C)(Oc2c1C)C1CCN(CC1)C1CC(F)(F)C1 |r| InChI=1S/C27H32ClF2N3O4S/c1-14-9-21(38-4)19(25(35)32-14)13-31-24(34)18-10-20(28)23-22(15(18)2)36-26(3,37-23)16-5-7-33(8-6-16)17-11-27(29,30)12-17/h9-10,16-17H,5-8,11-13H2,1-4H3,(H,31,34)(H,32,35) KIBOESQINKYUJB-UHFFFAOYSA-N 636171 US20230365541, Compound 12, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.740 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636171 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636171&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551812 486501813 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351534 CNC(=O)N1CCC(CC1)C1(C)Oc2c(O1)c(C)c(cc2Cl)C(=O)NCc1c(SC)cc(C)[nH]c1=O InChI=1S/C25H31ClN4O5S/c1-13-10-19(36-5)17(23(32)29-13)12-28-22(31)16-11-18(26)21-20(14(16)2)34-25(3,35-21)15-6-8-30(9-7-15)24(33)27-4/h10-11,15H,6-9,12H2,1-5H3,(H,27,33)(H,28,31)(H,29,32) VQCZDZKJEIDLMV-UHFFFAOYSA-N 636172 4-(7-chloro-2,4-dimethyl-5-(((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamoyl)benzo[d][1,3]dioxol-2-yl)-N-methylpiperidine-1-carboxamide ::US20230365541, Compound 13 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.430 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636172 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636172&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551813 486501814 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351535 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)C1CCN(CC1)S(C)(=O)=O InChI=1S/C24H30ClN3O6S2/c1-13-10-19(35-4)17(23(30)27-13)12-26-22(29)16-11-18(25)21-20(14(16)2)33-24(3,34-21)15-6-8-28(9-7-15)36(5,31)32/h10-11,15H,6-9,12H2,1-5H3,(H,26,29)(H,27,30) VVIPHFDXMHFJOB-UHFFFAOYSA-N 636173 7-chloro-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-(1-(methylsulfonyl)piperidin-4-yl)benzo[d][1,3]dioxole-5-carboxamide ::US20230365541, Compound 14 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.480 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636173&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551814 486501815 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351536 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)N1CCC2(CNC(=O)C2)C1 |r,wD:26.28,29.35,(7.69,-26.73,;7.69,-25.19,;6.36,-24.42,;5.03,-25.19,;3.69,-24.42,;2.36,-25.19,;3.69,-22.88,;5.03,-22.11,;5.03,-20.57,;6.36,-22.88,;7.69,-22.11,;9.01,-22.88,;10.35,-22.11,;10.35,-20.57,;11.68,-22.88,;11.68,-24.42,;13.01,-25.19,;13.01,-26.73,;14.35,-24.42,;15.81,-24.9,;16.72,-23.65,;18.05,-24.42,;15.81,-22.41,;14.35,-22.88,;13.01,-22.11,;13.01,-20.57,;18.05,-22.88,;18.05,-21.34,;19.39,-20.57,;20.72,-21.34,;20.72,-22.88,;19.39,-23.65,;22.05,-20.57,;22.21,-19.04,;23.72,-18.72,;24.49,-20.06,;25.52,-18.91,;26.93,-19.54,;26.77,-21.07,;27.91,-22.1,;25.26,-21.39,;23.46,-21.2,)| InChI=1S/C31H39ClN4O5S/c1-17-11-24(42-4)22(29(39)35-17)14-33-28(38)21-12-23(32)27-26(18(21)2)40-30(3,41-27)19-5-7-20(8-6-19)36-10-9-31(16-36)13-25(37)34-15-31/h11-12,19-20H,5-10,13-16H2,1-4H3,(H,33,38)(H,34,37)(H,35,39) NBUYDRUPIIKWHG-UHFFFAOYSA-N 636174 US20230365541, Compound 18, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.780 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636174 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636174&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551815 486501816 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351537 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)C1CCN(CC1)C(=O)c1csc(C)n1 InChI=1S/C28H31ClN4O5S2/c1-14-10-22(39-5)19(26(35)31-14)12-30-25(34)18-11-20(29)24-23(15(18)2)37-28(4,38-24)17-6-8-33(9-7-17)27(36)21-13-40-16(3)32-21/h10-11,13,17H,6-9,12H2,1-5H3,(H,30,34)(H,31,35) NRHOUYVEJILXGL-UHFFFAOYSA-N 636175 7-chloro-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-(1-(2-methylthiazole-4-carbonyl)piperidin-4-yl)benzo[d][1,3]dioxole-5-carboxamide ::US20230365541, Compound 21 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.610 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636175&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551816 486501817 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351538 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)C1CCN(CC1)C1CC1 InChI=1S/C26H32ClN3O4S/c1-14-11-21(35-4)19(25(32)29-14)13-28-24(31)18-12-20(27)23-22(15(18)2)33-26(3,34-23)16-7-9-30(10-8-16)17-5-6-17/h11-12,16-17H,5-10,13H2,1-4H3,(H,28,31)(H,29,32) LOVXDDSFYCWZQN-UHFFFAOYSA-N 636176 7-chloro-2-(1-cyclopropylpiperidin-4-yl)-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide ::US20230365541, Compound 24 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.580 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636176&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551817 486501818 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351539 CNS(=O)(=O)N1CCC(CC1)C1(C)Oc2c(O1)c(C)c(cc2Cl)C(=O)NCc1c(SC)cc(C)[nH]c1=O InChI=1S/C24H31ClN4O6S2/c1-13-10-19(36-5)17(23(31)28-13)12-27-22(30)16-11-18(25)21-20(14(16)2)34-24(3,35-21)15-6-8-29(9-7-15)37(32,33)26-4/h10-11,15,26H,6-9,12H2,1-5H3,(H,27,30)(H,28,31) AHANUZDGULBMDJ-UHFFFAOYSA-N 636177 7-chloro-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-(1-(N-methylsulfamoyl)piperidin-4-yl)benzo[d][1,3]dioxole-5-carboxamide ::US20230365541, Compound 26 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.520 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636177 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636177&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551818 486501819 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351540 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)C1CCN(CC2CC2)CC1 InChI=1S/C27H34ClN3O4S/c1-15-11-22(36-4)20(26(33)30-15)13-29-25(32)19-12-21(28)24-23(16(19)2)34-27(3,35-24)18-7-9-31(10-8-18)14-17-5-6-17/h11-12,17-18H,5-10,13-14H2,1-4H3,(H,29,32)(H,30,33) SWPCGSWYRVBGEJ-UHFFFAOYSA-N 636178 7-chloro-2-(1-(cyclopropylmethyl)piperidin-4-yl)-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl-d2)benzo[d][1,3]dioxole-5-carboxamide ::US20230365541, Compound 27 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.520 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636178&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551819 486501820 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351541 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)C1CCN(CC2CC(F)(F)C2)CC1 InChI=1S/C28H34ClF2N3O4S/c1-15-9-22(39-4)20(26(36)33-15)13-32-25(35)19-10-21(29)24-23(16(19)2)37-27(3,38-24)18-5-7-34(8-6-18)14-17-11-28(30,31)12-17/h9-10,17-18H,5-8,11-14H2,1-4H3,(H,32,35)(H,33,36) KONLMQQDZOPAIS-UHFFFAOYSA-N 636179 7-chloro-2-(1-((3,3-difluorocyclobutyl)methyl)piperidin-4-yl)-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl-d2)benzo[d][1,3]dioxole-5-carboxamide ::US20230365541, Compound 28 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.490 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636179&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551820 486501821 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351542 COC(=O)N1CCC(CC1)C1(C)Oc2c(O1)c(C)c(cc2Cl)C(=O)NCc1c(SC)cc(C)[nH]c1=O InChI=1S/C25H30ClN3O6S/c1-13-10-19(36-5)17(23(31)28-13)12-27-22(30)16-11-18(26)21-20(14(16)2)34-25(3,35-21)15-6-8-29(9-7-15)24(32)33-4/h10-11,15H,6-9,12H2,1-5H3,(H,27,30)(H,28,31) SQLMKVXDKGRKGT-UHFFFAOYSA-N 636180 methyl-4-(7-chloro-2,4-dimethyl-5-(((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamoyl)benzo[d][1,3]dioxol-2-yl)piperidine-1-carboxylate ::US20230365541, Compound 29 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.440 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636180&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551821 486501822 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351543 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)C1CCN(CC2(CC2)C#N)CC1 InChI=1S/C28H33ClN4O4S/c1-16-11-22(38-4)20(26(35)32-16)13-31-25(34)19-12-21(29)24-23(17(19)2)36-27(3,37-24)18-5-9-33(10-6-18)15-28(14-30)7-8-28/h11-12,18H,5-10,13,15H2,1-4H3,(H,31,34)(H,32,35) ODZYRLVIEUJZQG-UHFFFAOYSA-N 636181 7-chloro-2-(1-((1-cyanocyclopropyl)methyl)piperidin-4-yl)-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide ::US20230365541, Compound 30 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.660 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636181 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636181&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551822 486501823 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351544 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)C1CCN(CC2CC2(F)F)CC1 InChI=1S/C27H32ClF2N3O4S/c1-14-9-21(38-4)19(25(35)32-14)12-31-24(34)18-10-20(28)23-22(15(18)2)36-26(3,37-23)16-5-7-33(8-6-16)13-17-11-27(17,29)30/h9-10,16-17H,5-8,11-13H2,1-4H3,(H,31,34)(H,32,35) IQUOHDNBDSHVFY-UHFFFAOYSA-N 636182 7-chloro-2-(1-((2,2-difluorocyclopropyl)methyl)piperidin-4-yl)-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide ::US20230365541, Compound 31 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.520 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636182 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636182&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551823 486501824 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351545 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)C1CCN(CC2(F)CC2)CC1 InChI=1S/C27H33ClFN3O4S/c1-15-11-21(37-4)19(25(34)31-15)13-30-24(33)18-12-20(28)23-22(16(18)2)35-26(3,36-23)17-5-9-32(10-6-17)14-27(29)7-8-27/h11-12,17H,5-10,13-14H2,1-4H3,(H,30,33)(H,31,34) HXIXVBQJCILKHW-UHFFFAOYSA-N 636183 7-chloro-2-(1-((1-fluorocyclopropyl)methyl)piperidin-4-yl)-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide ::US20230365541, Compound 32 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.580 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636183&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551824 486501825 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351546 COC1CC(C1)N1CCC(CC1)C1(C)Oc2c(O1)c(C)c(cc2Cl)C(=O)NCc1c(SC)cc(C)[nH]c1=O |(12.73,-20.4,;11.4,-19.63,;10.06,-20.4,;9.66,-21.88,;8.18,-21.49,;8.57,-20,;6.84,-22.26,;6.84,-23.8,;5.51,-24.57,;4.17,-23.8,;4.17,-22.26,;5.51,-21.49,;2.84,-24.57,;3.75,-25.81,;1.94,-25.81,;.47,-25.34,;.47,-23.8,;1.94,-23.32,;-.86,-23.03,;-.86,-21.49,;-2.2,-23.8,;-2.2,-25.34,;-.86,-26.11,;-.86,-27.65,;-3.53,-23.03,;-3.53,-21.49,;-4.86,-23.8,;-6.2,-23.03,;-7.53,-23.8,;-7.53,-25.34,;-6.2,-26.11,;-6.2,-27.65,;-8.86,-26.11,;-10.2,-25.34,;-11.53,-26.11,;-10.2,-23.8,;-8.86,-23.03,;-8.86,-21.49,)| InChI=1S/C28H36ClN3O5S/c1-15-10-23(38-5)21(27(34)31-15)14-30-26(33)20-13-22(29)25-24(16(20)2)36-28(3,37-25)17-6-8-32(9-7-17)18-11-19(12-18)35-4/h10,13,17-19H,6-9,11-12,14H2,1-5H3,(H,30,33)(H,31,34) ABWKMNKJEPDFGS-UHFFFAOYSA-N 636184 7-chloro-2-(1-(3-methoxycyclobutyl)piperidin-4-yl)-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide ::US20230365541, Compound 33 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.570 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636184 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636184&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551825 486501826 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351547 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)N[C@H]1C[C@H](F)C1 |r,wU:33.36,wD:26.28,35.39,29.35,(-8.49,-30.05,;-8.49,-28.51,;-9.83,-27.74,;-11.16,-28.51,;-12.5,-27.74,;-13.83,-28.51,;-12.5,-26.2,;-11.16,-25.43,;-11.16,-23.89,;-9.83,-26.2,;-8.49,-25.43,;-7.16,-26.2,;-5.83,-25.43,;-5.83,-23.89,;-4.49,-26.2,;-4.49,-27.74,;-3.16,-28.51,;-3.16,-30.05,;-1.83,-27.74,;-.36,-28.21,;.54,-26.97,;1.88,-27.74,;-.36,-25.72,;-1.83,-26.2,;-3.16,-25.43,;-3.16,-23.89,;1.88,-26.2,;1.88,-24.66,;3.21,-23.89,;4.54,-24.66,;4.54,-26.2,;3.21,-26.97,;5.88,-23.89,;7.21,-24.66,;8.7,-24.26,;9.1,-25.75,;10.43,-26.52,;7.61,-26.14,)| InChI=1S/C28H35ClFN3O4S/c1-14-9-23(38-4)21(27(35)32-14)13-31-26(34)20-12-22(29)25-24(15(20)2)36-28(3,37-25)16-5-7-18(8-6-16)33-19-10-17(30)11-19/h9,12,16-19,33H,5-8,10-11,13H2,1-4H3,(H,31,34)(H,32,35) SCHSLNNCDSSBLA-UHFFFAOYSA-N 636185 US20230365541, Compound 34, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.570 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636185 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636185&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551826 486501827 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351548 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)N[C@H]1C[C@H](F)C1 |r,wU:29.35,33.36,wD:26.28,35.39,(-6.68,-36.74,;-6.68,-35.2,;-8.01,-34.43,;-9.34,-35.2,;-10.68,-34.43,;-12.01,-35.2,;-10.68,-32.89,;-9.34,-32.12,;-9.34,-30.58,;-8.01,-32.89,;-6.68,-32.12,;-5.34,-32.89,;-4.01,-32.12,;-4.01,-30.58,;-2.68,-32.89,;-2.68,-34.43,;-1.34,-35.2,;-1.34,-36.74,;-.01,-34.43,;1.46,-34.9,;2.36,-33.66,;3.7,-34.43,;1.46,-32.41,;-.01,-32.89,;-1.34,-32.12,;-1.34,-30.58,;3.7,-32.89,;5.03,-33.66,;6.36,-32.89,;6.36,-31.35,;5.03,-30.58,;3.7,-31.35,;7.7,-30.58,;9.03,-31.35,;10.52,-30.95,;10.92,-32.44,;12.25,-33.21,;9.43,-32.84,)| InChI=1S/C28H35ClFN3O4S/c1-14-9-23(38-4)21(27(35)32-14)13-31-26(34)20-12-22(29)25-24(15(20)2)36-28(3,37-25)16-5-7-18(8-6-16)33-19-10-17(30)11-19/h9,12,16-19,33H,5-8,10-11,13H2,1-4H3,(H,31,34)(H,32,35) SCHSLNNCDSSBLA-UHFFFAOYSA-N 636186 US20230365541, Compound 34, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.570 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636186&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551826 486501828 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351549 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)C1CCC(CC1)N(C)C1CC(F)(F)C1 |(-6.3,-25.05,;-6.3,-23.51,;-7.63,-22.74,;-8.97,-23.51,;-10.3,-22.74,;-11.64,-23.51,;-10.3,-21.2,;-8.97,-20.43,;-8.97,-18.89,;-7.63,-21.2,;-6.3,-20.43,;-4.98,-21.2,;-3.65,-20.43,;-3.65,-18.89,;-2.31,-21.2,;-2.31,-22.74,;-.98,-23.51,;-.98,-25.05,;.35,-22.74,;1.82,-23.21,;2.72,-21.97,;4.06,-22.74,;1.82,-20.72,;.35,-21.2,;-.98,-20.43,;-.98,-18.89,;4.06,-21.2,;5.39,-21.97,;6.72,-21.2,;6.72,-19.66,;5.39,-18.89,;4.06,-19.66,;8.06,-18.89,;8.06,-17.35,;9.39,-19.66,;9.79,-21.14,;11.28,-20.75,;12.82,-20.75,;12.05,-22.08,;10.88,-19.26,)| InChI=1S/C29H36ClF2N3O4S/c1-15-10-23(40-5)21(27(37)34-15)14-33-26(36)20-11-22(30)25-24(16(20)2)38-28(3,39-25)17-6-8-18(9-7-17)35(4)19-12-29(31,32)13-19/h10-11,17-19H,6-9,12-14H2,1-5H3,(H,33,36)(H,34,37) XWZDYQZFOFOYSQ-UHFFFAOYSA-N 636187 7-chloro-2-(4-((3,3-difluorocyclobutyl)(methyl)amino)cyclohexyl)-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide ::US20230365541, Compound 35 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.590 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636187&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551827 486501829 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351550 CNC(=O)N1CC2CCC(C1)C2[C@@]1(C)Oc2c(O1)c(C)c(cc2Cl)C(=O)NCc1c(SC)cc(C)[nH]c1=O |r| InChI=1S/C27H33ClN4O5S/c1-13-8-20(38-5)18(25(34)31-13)10-30-24(33)17-9-19(28)23-22(14(17)2)36-27(3,37-23)21-15-6-7-16(21)12-32(11-15)26(35)29-4/h8-9,15-16,21H,6-7,10-12H2,1-5H3,(H,29,35)(H,30,33)(H,31,34) JBIKUQBURLJLKB-UHFFFAOYSA-N 636188 8-(7-chloro-2,4-dimethyl-5-(((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamoyl)benzo[d][1,3]dioxol-2-yl)-N-methyl-3-azabicyclo[3.2.1]octane-3-carboxamide ::US20230365541, Compound 36 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.550 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636188&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551828 486501830 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351551 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)C1CCN(CC2CCC2)CC1 InChI=1S/C28H36ClN3O4S/c1-16-12-23(37-4)21(27(34)31-16)14-30-26(33)20-13-22(29)25-24(17(20)2)35-28(3,36-25)19-8-10-32(11-9-19)15-18-6-5-7-18/h12-13,18-19H,5-11,14-15H2,1-4H3,(H,30,33)(H,31,34) SQSLZKUPQGLEIT-UHFFFAOYSA-N 636189 7-chloro-2-(1-(cyclobutylmethyl)piperidin-4-yl)-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide ::US20230365541, Compound 37 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.440 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636189&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551829 486501831 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351552 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)C1CCN(CC2COC2)CC1 InChI=1S/C27H34ClN3O5S/c1-15-9-22(37-4)20(26(33)30-15)11-29-25(32)19-10-21(28)24-23(16(19)2)35-27(3,36-24)18-5-7-31(8-6-18)12-17-13-34-14-17/h9-10,17-18H,5-8,11-14H2,1-4H3,(H,29,32)(H,30,33) LMFSXISVNQLEJL-UHFFFAOYSA-N 636190 7-chloro-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-(1-(oxetan-3-ylmethyl)piperidin-4-yl)benzo[d][1,3]dioxole-5-carboxamide ::US20230365541, Compound 38 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.700 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636190&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551830 486501832 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351553 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)c1ccccn1 |r,wU:26.28,wD:29.35,(-6.18,-37.37,;-6.18,-35.83,;-7.51,-35.06,;-8.85,-35.83,;-10.18,-35.06,;-11.51,-35.83,;-10.18,-33.52,;-8.85,-32.75,;-8.85,-31.21,;-7.51,-33.52,;-6.18,-32.75,;-4.84,-33.52,;-3.51,-32.75,;-3.51,-31.21,;-2.18,-33.52,;-2.18,-35.06,;-.84,-35.83,;-.84,-37.37,;.49,-35.06,;1.96,-35.54,;2.86,-34.29,;3.95,-35.38,;1.96,-33.05,;.49,-33.52,;-.84,-32.75,;-.84,-31.21,;3.95,-33.21,;3.55,-31.72,;4.64,-30.63,;6.13,-31.03,;6.53,-32.52,;5.44,-33.6,;7.22,-29.94,;6.82,-28.45,;7.91,-27.36,;9.39,-27.76,;9.79,-29.25,;8.7,-30.34,)| InChI=1S/C29H32ClN3O4S/c1-16-13-24(38-4)21(28(35)33-16)15-32-27(34)20-14-22(30)26-25(17(20)2)36-29(3,37-26)19-10-8-18(9-11-19)23-7-5-6-12-31-23/h5-7,12-14,18-19H,8-11,15H2,1-4H3,(H,32,34)(H,33,35) MKLFUZSEULTTJG-UHFFFAOYSA-N 636191 US20230365541, Compound 39, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.420 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636191&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551831 486501833 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351554 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)c1ccccn1 |r,wU:26.28,29.35,(-6.18,-37.37,;-6.18,-35.83,;-7.51,-35.06,;-8.85,-35.83,;-10.18,-35.06,;-11.51,-35.83,;-10.18,-33.52,;-8.85,-32.75,;-8.85,-31.21,;-7.51,-33.52,;-6.18,-32.75,;-4.84,-33.52,;-3.51,-32.75,;-3.51,-31.21,;-2.18,-33.52,;-2.18,-35.06,;-.84,-35.83,;-.84,-37.37,;.49,-35.06,;1.96,-35.54,;2.86,-34.29,;3.95,-35.38,;1.96,-33.05,;.49,-33.52,;-.84,-32.75,;-.84,-31.21,;3.95,-33.21,;5.44,-33.6,;6.53,-32.52,;6.13,-31.03,;4.64,-30.63,;3.55,-31.72,;7.22,-29.94,;6.82,-28.45,;7.91,-27.36,;9.39,-27.76,;9.79,-29.25,;8.7,-30.34,)| InChI=1S/C29H32ClN3O4S/c1-16-13-24(38-4)21(28(35)33-16)15-32-27(34)20-14-22(30)26-25(17(20)2)36-29(3,37-26)19-10-8-18(9-11-19)23-7-5-6-12-31-23/h5-7,12-14,18-19H,8-11,15H2,1-4H3,(H,32,34)(H,33,35) MKLFUZSEULTTJG-UHFFFAOYSA-N 636192 US20230365541, Compound 39, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.580 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636192&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551831 486501834 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351555 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@H](CNC2CC(F)(F)C2)CC1 |r,wU:26.28,wD:29.32,(-7.47,-18.93,;-7.47,-17.39,;-8.8,-16.62,;-10.13,-17.39,;-11.47,-16.62,;-12.8,-17.39,;-11.47,-15.08,;-10.13,-14.31,;-10.13,-12.77,;-8.8,-15.08,;-7.47,-14.31,;-6.13,-15.08,;-4.8,-14.31,;-4.8,-12.77,;-3.47,-15.08,;-3.47,-16.62,;-2.13,-17.39,;-2.13,-18.93,;-.8,-16.62,;.67,-17.1,;1.57,-15.85,;2.91,-16.62,;.67,-14.61,;-.8,-15.08,;-2.13,-14.31,;-2.13,-12.77,;2.91,-15.08,;2.91,-13.54,;4.24,-12.77,;5.57,-13.54,;6.91,-12.77,;8.24,-13.54,;9.57,-12.77,;11.06,-13.17,;11.46,-11.69,;13,-11.69,;12.23,-10.35,;9.97,-11.29,;5.57,-15.08,;4.24,-15.85,)| InChI=1S/C29H36ClF2N3O4S/c1-15-9-23(40-4)21(27(37)35-15)14-34-26(36)20-10-22(30)25-24(16(20)2)38-28(3,39-25)18-7-5-17(6-8-18)13-33-19-11-29(31,32)12-19/h9-10,17-19,33H,5-8,11-14H2,1-4H3,(H,34,36)(H,35,37) JVVBBCYIIAWEEV-UHFFFAOYSA-N 636193 US20230365541, Compound 40, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.610 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636193&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551832 486501835 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351556 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@H](CNC2CC(F)(F)C2)CC1 |r,wU:26.28,29.32,(-7.47,-18.93,;-7.47,-17.39,;-8.8,-16.62,;-10.13,-17.39,;-11.47,-16.62,;-12.8,-17.39,;-11.47,-15.08,;-10.13,-14.31,;-10.13,-12.77,;-8.8,-15.08,;-7.47,-14.31,;-6.13,-15.08,;-4.8,-14.31,;-4.8,-12.77,;-3.47,-15.08,;-3.47,-16.62,;-2.13,-17.39,;-2.13,-18.93,;-.8,-16.62,;.67,-17.1,;1.57,-15.85,;2.91,-16.62,;.67,-14.61,;-.8,-15.08,;-2.13,-14.31,;-2.13,-12.77,;2.91,-15.08,;4.24,-15.85,;5.57,-15.08,;5.57,-13.54,;6.91,-12.77,;8.24,-13.54,;9.57,-12.77,;11.06,-13.17,;11.46,-11.69,;13,-11.69,;12.23,-10.35,;9.97,-11.29,;4.24,-12.77,;2.91,-13.54,)| InChI=1S/C29H36ClF2N3O4S/c1-15-9-23(40-4)21(27(37)35-15)14-34-26(36)20-10-22(30)25-24(16(20)2)38-28(3,39-25)18-7-5-17(6-8-18)13-33-19-11-29(31,32)12-19/h9-10,17-19,33H,5-8,11-14H2,1-4H3,(H,34,36)(H,35,37) JVVBBCYIIAWEEV-UHFFFAOYSA-N 636194 US20230365541, Compound 40, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.510 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636194&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551832 486501836 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351557 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)N[C@@H]1C[C@H](F)C1 |r,wU:26.28,wD:29.35,33.36,35.39,(-16.15,-22.58,;-16.15,-21.04,;-17.49,-20.27,;-18.82,-21.04,;-20.16,-20.27,;-21.49,-21.04,;-20.16,-18.73,;-18.82,-17.96,;-18.82,-16.42,;-17.49,-18.73,;-16.15,-17.96,;-14.82,-18.73,;-13.49,-17.96,;-13.49,-16.42,;-12.15,-18.73,;-12.15,-20.27,;-10.82,-21.04,;-10.82,-22.58,;-9.49,-20.27,;-8.02,-20.74,;-7.12,-19.5,;-5.78,-20.27,;-8.02,-18.25,;-9.49,-18.73,;-10.82,-17.96,;-10.82,-16.42,;-5.78,-18.73,;-5.78,-17.19,;-4.45,-16.42,;-3.12,-17.19,;-3.12,-18.73,;-4.45,-19.5,;-1.78,-16.42,;-.45,-17.19,;1.04,-16.79,;1.44,-18.28,;2.77,-19.05,;-.05,-18.68,)| InChI=1S/C28H35ClFN3O4S/c1-14-9-23(38-4)21(27(35)32-14)13-31-26(34)20-12-22(29)25-24(15(20)2)36-28(3,37-25)16-5-7-18(8-6-16)33-19-10-17(30)11-19/h9,12,16-19,33H,5-8,10-11,13H2,1-4H3,(H,31,34)(H,32,35) SCHSLNNCDSSBLA-UHFFFAOYSA-N 636195 US20230365541, Compound 41, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.520 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636195&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551826 486501837 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351558 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)N[C@@H]1C[C@H](F)C1 |r,wU:26.28,29.35,wD:33.36,35.39,(-16.15,-22.58,;-16.15,-21.04,;-17.49,-20.27,;-18.82,-21.04,;-20.16,-20.27,;-21.49,-21.04,;-20.16,-18.73,;-18.82,-17.96,;-18.82,-16.42,;-17.49,-18.73,;-16.15,-17.96,;-14.82,-18.73,;-13.49,-17.96,;-13.49,-16.42,;-12.15,-18.73,;-12.15,-20.27,;-10.82,-21.04,;-10.82,-22.58,;-9.49,-20.27,;-8.02,-20.74,;-7.12,-19.5,;-5.78,-20.27,;-8.02,-18.25,;-9.49,-18.73,;-10.82,-17.96,;-10.82,-16.42,;-5.78,-18.73,;-4.45,-19.5,;-3.12,-18.73,;-3.12,-17.19,;-4.45,-16.42,;-5.78,-17.19,;-1.78,-16.42,;-.45,-17.19,;1.04,-16.79,;1.44,-18.28,;2.77,-19.05,;-.05,-18.68,)| InChI=1S/C28H35ClFN3O4S/c1-14-9-23(38-4)21(27(35)32-14)13-31-26(34)20-12-22(29)25-24(15(20)2)36-28(3,37-25)16-5-7-18(8-6-16)33-19-10-17(30)11-19/h9,12,16-19,33H,5-8,10-11,13H2,1-4H3,(H,31,34)(H,32,35) SCHSLNNCDSSBLA-UHFFFAOYSA-N 636196 US20230365541, Compound 41, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.440 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636196&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551826 486501838 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351559 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)N1CC2CN(C)CC2C1 |r,wU:26.28,wD:29.35,(-9.14,-19.26,;-9.14,-17.72,;-10.48,-16.95,;-11.81,-17.72,;-13.15,-16.95,;-14.48,-17.72,;-13.15,-15.41,;-11.81,-14.64,;-11.81,-13.1,;-10.48,-15.41,;-9.14,-14.64,;-7.81,-15.41,;-6.48,-14.64,;-6.48,-13.1,;-5.14,-15.41,;-5.14,-16.95,;-3.81,-17.72,;-3.81,-19.26,;-2.48,-16.95,;-1.01,-17.43,;-.11,-16.18,;.98,-17.27,;-1.01,-14.94,;-2.48,-15.41,;-3.81,-14.64,;-3.81,-13.1,;1.23,-15.41,;1.23,-13.87,;2.56,-13.1,;3.89,-13.87,;3.89,-15.41,;2.56,-16.18,;5.23,-13.1,;6.64,-13.73,;7.67,-12.59,;9.17,-12.27,;9.33,-10.73,;10.67,-9.96,;7.93,-10.11,;6.9,-11.25,;5.39,-11.57,)| InChI=1S/C31H41ClN4O4S/c1-17-10-26(41-5)24(30(38)34-17)12-33-29(37)23-11-25(32)28-27(18(23)2)39-31(3,40-28)21-6-8-22(9-7-21)36-15-19-13-35(4)14-20(19)16-36/h10-11,19-22H,6-9,12-16H2,1-5H3,(H,33,37)(H,34,38) GZFSJOWICWLRML-UHFFFAOYSA-N 636197 US20230365541, Compound 42, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.340 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636197&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551833 486501839 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351560 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)N1CC2CN(C)CC2C1 |r,wU:26.28,29.35,(-9.14,-19.26,;-9.14,-17.72,;-10.48,-16.95,;-11.81,-17.72,;-13.15,-16.95,;-14.48,-17.72,;-13.15,-15.41,;-11.81,-14.64,;-11.81,-13.1,;-10.48,-15.41,;-9.14,-14.64,;-7.81,-15.41,;-6.48,-14.64,;-6.48,-13.1,;-5.14,-15.41,;-5.14,-16.95,;-3.81,-17.72,;-3.81,-19.26,;-2.48,-16.95,;-1.01,-17.43,;-.11,-16.18,;.98,-17.27,;-1.01,-14.94,;-2.48,-15.41,;-3.81,-14.64,;-3.81,-13.1,;1.23,-15.41,;2.56,-16.18,;3.89,-15.41,;3.89,-13.87,;2.56,-13.1,;1.23,-13.87,;5.23,-13.1,;6.64,-13.73,;7.67,-12.59,;9.17,-12.27,;9.33,-10.73,;10.67,-9.96,;7.93,-10.11,;6.9,-11.25,;5.39,-11.57,)| InChI=1S/C31H41ClN4O4S/c1-17-10-26(41-5)24(30(38)34-17)12-33-29(37)23-11-25(32)28-27(18(23)2)39-31(3,40-28)21-6-8-22(9-7-21)36-15-19-13-35(4)14-20(19)16-36/h10-11,19-22H,6-9,12-16H2,1-5H3,(H,33,37)(H,34,38) GZFSJOWICWLRML-UHFFFAOYSA-N 636198 US20230365541, Compound 42, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.230 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636198&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551833 486501840 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351561 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)N1CC(C1)N1CCCC1 |r,wU:29.35,wD:26.28,(-5.2,-36.99,;-5.2,-35.45,;-6.53,-34.68,;-7.87,-35.45,;-9.2,-34.68,;-10.53,-35.45,;-9.2,-33.14,;-7.87,-32.37,;-7.87,-30.83,;-6.53,-33.14,;-5.2,-32.37,;-3.87,-33.14,;-2.53,-32.37,;-2.53,-30.83,;-1.2,-33.14,;-1.2,-34.68,;.14,-35.45,;.14,-36.99,;1.47,-34.68,;2.93,-35.16,;3.84,-33.91,;4.93,-35,;2.93,-32.66,;1.47,-33.14,;.14,-32.37,;.14,-30.83,;5.17,-33.14,;6.51,-33.91,;7.84,-33.14,;7.84,-31.6,;6.51,-30.83,;5.17,-31.6,;9.17,-30.83,;10.66,-31.23,;11.06,-29.74,;9.57,-29.34,;12.39,-28.97,;13.8,-29.6,;14.83,-28.45,;14.06,-27.12,;12.55,-27.44,)| InChI=1S/C31H41ClN4O4S/c1-18-13-26(41-4)24(30(38)34-18)15-33-29(37)23-14-25(32)28-27(19(23)2)39-31(3,40-28)20-7-9-21(10-8-20)36-16-22(17-36)35-11-5-6-12-35/h13-14,20-22H,5-12,15-17H2,1-4H3,(H,33,37)(H,34,38) MQCMLPWSHXEOSU-UHFFFAOYSA-N 636199 US20230365541, Compound 43, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.490 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636199&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551834 486501841 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351562 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)N1CC(C1)N1CCCC1 |r,wU:26.28,29.35,(-5.2,-36.99,;-5.2,-35.45,;-6.53,-34.68,;-7.87,-35.45,;-9.2,-34.68,;-10.53,-35.45,;-9.2,-33.14,;-7.87,-32.37,;-7.87,-30.83,;-6.53,-33.14,;-5.2,-32.37,;-3.87,-33.14,;-2.53,-32.37,;-2.53,-30.83,;-1.2,-33.14,;-1.2,-34.68,;.13,-35.45,;.13,-36.99,;1.47,-34.68,;2.93,-35.15,;3.84,-33.91,;4.93,-34.99,;2.93,-32.66,;1.47,-33.14,;.13,-32.37,;.13,-30.83,;5.17,-33.14,;6.51,-33.91,;7.84,-33.14,;7.84,-31.6,;6.51,-30.83,;5.17,-31.6,;9.17,-30.83,;10.66,-31.22,;11.06,-29.74,;9.57,-29.34,;12.39,-28.97,;13.8,-29.59,;14.83,-28.45,;14.06,-27.12,;12.55,-27.44,)| InChI=1S/C31H41ClN4O4S/c1-18-13-26(41-4)24(30(38)34-18)15-33-29(37)23-14-25(32)28-27(19(23)2)39-31(3,40-28)20-7-9-21(10-8-20)36-16-22(17-36)35-11-5-6-12-35/h13-14,20-22H,5-12,15-17H2,1-4H3,(H,33,37)(H,34,38) MQCMLPWSHXEOSU-UHFFFAOYSA-N 636200 US20230365541, Compound 43, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.420 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636200&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551834 486501842 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351563 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)NC1CC(F)(F)C1 |r,wU:29.35,wD:26.28,(-6.57,-12.84,;-6.57,-11.3,;-7.91,-10.53,;-9.24,-11.3,;-10.58,-10.53,;-11.91,-11.3,;-10.58,-8.99,;-9.24,-8.22,;-9.24,-6.68,;-7.91,-8.99,;-6.57,-8.22,;-5.24,-8.99,;-3.91,-8.22,;-3.91,-6.68,;-2.57,-8.99,;-2.57,-10.53,;-1.24,-11.3,;-1.24,-12.84,;.09,-10.53,;1.56,-11.01,;2.46,-9.76,;3.55,-10.85,;1.56,-8.51,;.09,-8.99,;-1.24,-8.22,;-1.24,-6.68,;3.8,-8.99,;5.13,-9.76,;6.46,-8.99,;6.46,-7.45,;5.13,-6.68,;3.8,-7.45,;7.8,-6.68,;9.13,-7.45,;9.53,-8.94,;11.02,-8.54,;12.56,-8.54,;11.79,-9.87,;10.62,-7.05,)| InChI=1S/C28H34ClF2N3O4S/c1-14-9-22(39-4)20(26(36)33-14)13-32-25(35)19-10-21(29)24-23(15(19)2)37-27(3,38-24)16-5-7-17(8-6-16)34-18-11-28(30,31)12-18/h9-10,16-18,34H,5-8,11-13H2,1-4H3,(H,32,35)(H,33,36) VXEJHUGGAMXCBU-UHFFFAOYSA-N 636201 US20230365541, Compound 44, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.480 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636201 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636201&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551835 486501843 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351564 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)NC1CC(F)(F)C1 |r,wU:26.28,29.35,(-6.57,-12.84,;-6.57,-11.3,;-7.91,-10.53,;-9.24,-11.3,;-10.58,-10.53,;-11.91,-11.3,;-10.58,-8.99,;-9.24,-8.22,;-9.24,-6.68,;-7.91,-8.99,;-6.57,-8.22,;-5.24,-8.99,;-3.91,-8.22,;-3.91,-6.68,;-2.57,-8.99,;-2.57,-10.53,;-1.24,-11.3,;-1.24,-12.84,;.09,-10.53,;1.56,-11.01,;2.46,-9.76,;3.55,-10.85,;1.56,-8.51,;.09,-8.99,;-1.24,-8.22,;-1.24,-6.68,;3.8,-8.99,;5.13,-9.76,;6.46,-8.99,;6.46,-7.45,;5.13,-6.68,;3.8,-7.45,;7.8,-6.68,;9.13,-7.45,;9.53,-8.94,;11.02,-8.54,;12.56,-8.54,;11.79,-9.87,;10.62,-7.05,)| InChI=1S/C28H34ClF2N3O4S/c1-14-9-22(39-4)20(26(36)33-14)13-32-25(35)19-10-21(29)24-23(15(19)2)37-27(3,38-24)16-5-7-17(8-6-16)34-18-11-28(30,31)12-18/h9-10,16-18,34H,5-8,11-13H2,1-4H3,(H,32,35)(H,33,36) VXEJHUGGAMXCBU-UHFFFAOYSA-N 636202 US20230365541, Compound 44, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.510 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636202 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636202&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551835 486501844 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351565 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)N[C@H]1C[C@H](O)C1 |r,wU:26.28,33.36,wD:29.35,35.39,(-6.8,22.49,;-6.8,24.03,;-8.13,24.8,;-9.46,24.03,;-10.8,24.8,;-12.13,24.03,;-10.8,26.34,;-9.46,27.11,;-9.46,28.65,;-8.13,26.34,;-6.8,27.11,;-5.46,26.34,;-4.13,27.11,;-4.13,28.65,;-2.79,26.34,;-2.79,24.8,;-1.46,24.03,;-1.46,22.49,;-.13,24.8,;1.34,24.32,;2.24,25.57,;3.58,24.8,;1.34,26.81,;-.13,26.34,;-1.46,27.11,;-1.46,28.65,;3.58,26.34,;3.58,27.88,;4.91,28.65,;6.24,27.88,;6.24,26.34,;4.91,25.57,;7.58,28.65,;8.91,27.88,;10.4,28.27,;10.8,26.79,;12.13,26.02,;9.31,26.39,)| InChI=1S/C28H36ClN3O5S/c1-14-9-23(38-4)21(27(35)31-14)13-30-26(34)20-12-22(29)25-24(15(20)2)36-28(3,37-25)16-5-7-17(8-6-16)32-18-10-19(33)11-18/h9,12,16-19,32-33H,5-8,10-11,13H2,1-4H3,(H,30,34)(H,31,35) FZSKLSUQYAZGAZ-UHFFFAOYSA-N 636203 US20230365541, Compound 45, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.280 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636203&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551836 486501845 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351566 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)N[C@H]1C[C@H](O)C1 |r,wU:26.28,29.35,33.36,wD:35.39,(-6.8,22.49,;-6.8,24.03,;-8.13,24.8,;-9.46,24.03,;-10.8,24.8,;-12.13,24.03,;-10.8,26.34,;-9.46,27.11,;-9.46,28.65,;-8.13,26.34,;-6.8,27.11,;-5.46,26.34,;-4.13,27.11,;-4.13,28.65,;-2.79,26.34,;-2.79,24.8,;-1.46,24.03,;-1.46,22.49,;-.13,24.8,;1.34,24.32,;2.24,25.57,;3.58,24.8,;1.34,26.81,;-.13,26.34,;-1.46,27.11,;-1.46,28.65,;3.58,26.34,;4.91,25.57,;6.24,26.34,;6.24,27.88,;4.91,28.65,;3.58,27.88,;7.58,28.65,;8.91,27.88,;10.4,28.27,;10.8,26.79,;12.13,26.02,;9.31,26.39,)| InChI=1S/C28H36ClN3O5S/c1-14-9-23(38-4)21(27(35)31-14)13-30-26(34)20-12-22(29)25-24(15(20)2)36-28(3,37-25)16-5-7-17(8-6-16)32-18-10-19(33)11-18/h9,12,16-19,32-33H,5-8,10-11,13H2,1-4H3,(H,30,34)(H,31,35) FZSKLSUQYAZGAZ-UHFFFAOYSA-N 636204 US20230365541, Compound 45, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.350 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636204&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551836 486501846 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351567 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)C(=O)N1CC(F)(F)C1 |r,wU:29.35,wD:26.28,(-6.86,-17.49,;-6.86,-15.95,;-8.2,-15.18,;-9.53,-15.95,;-10.86,-15.18,;-12.2,-15.95,;-10.86,-13.64,;-9.53,-12.87,;-9.53,-11.33,;-8.2,-13.64,;-6.86,-12.87,;-5.53,-13.64,;-4.2,-12.87,;-4.2,-11.33,;-2.86,-13.64,;-2.86,-15.18,;-1.53,-15.95,;-1.53,-17.49,;-.2,-15.18,;1.27,-15.66,;2.17,-14.41,;3.51,-15.18,;1.27,-13.16,;-.2,-13.64,;-1.53,-12.87,;-1.53,-11.33,;3.51,-13.64,;4.84,-14.41,;6.18,-13.64,;6.18,-12.1,;4.84,-11.33,;3.51,-12.1,;7.51,-11.33,;7.51,-9.79,;8.84,-12.1,;9.24,-13.59,;10.73,-13.19,;12.27,-13.19,;11.5,-14.52,;10.33,-11.7,)| InChI=1S/C28H32ClF2N3O5S/c1-14-9-21(40-4)19(25(36)33-14)11-32-24(35)18-10-20(29)23-22(15(18)2)38-27(3,39-23)17-7-5-16(6-8-17)26(37)34-12-28(30,31)13-34/h9-10,16-17H,5-8,11-13H2,1-4H3,(H,32,35)(H,33,36) AVOQEGDMTMEEIO-UHFFFAOYSA-N 636205 US20230365541, Compound 47, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.340 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636205 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636205&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551837 486501847 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351568 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)C(=O)N1CC(F)(F)C1 |r,wU:26.28,29.35,(-6.86,-17.49,;-6.86,-15.95,;-8.2,-15.18,;-9.53,-15.95,;-10.86,-15.18,;-12.2,-15.95,;-10.86,-13.64,;-9.53,-12.87,;-9.53,-11.33,;-8.2,-13.64,;-6.86,-12.87,;-5.53,-13.64,;-4.2,-12.87,;-4.2,-11.33,;-2.86,-13.64,;-2.86,-15.18,;-1.53,-15.95,;-1.53,-17.49,;-.2,-15.18,;1.27,-15.66,;2.17,-14.41,;3.51,-15.18,;1.27,-13.17,;-.2,-13.64,;-1.53,-12.87,;-1.53,-11.33,;3.51,-13.64,;4.84,-14.41,;6.18,-13.64,;6.18,-12.1,;4.84,-11.33,;3.51,-12.1,;7.51,-11.33,;7.51,-9.79,;8.84,-12.1,;9.24,-13.59,;10.73,-13.19,;12.27,-13.19,;11.5,-14.52,;10.33,-11.7,)| InChI=1S/C28H32ClF2N3O5S/c1-14-9-21(40-4)19(25(36)33-14)11-32-24(35)18-10-20(29)23-22(15(18)2)38-27(3,39-23)17-7-5-16(6-8-17)26(37)34-12-28(30,31)13-34/h9-10,16-17H,5-8,11-13H2,1-4H3,(H,32,35)(H,33,36) AVOQEGDMTMEEIO-UHFFFAOYSA-N 636206 US20230365541, Compound 47, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.920 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636206 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636206&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551837 486501848 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351569 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)N1CC[Si](C)(C)CC1 |r,wD:26.28,29.35,(-19.84,-4.8,;-19.84,-3.26,;-21.17,-2.49,;-22.51,-3.26,;-23.84,-2.49,;-25.18,-3.26,;-23.84,-.95,;-22.51,-.18,;-22.51,1.36,;-21.17,-.95,;-19.84,-.18,;-18.51,-.95,;-17.17,-.18,;-17.17,1.36,;-15.84,-.95,;-15.84,-2.49,;-14.51,-3.26,;-14.51,-4.8,;-13.17,-2.49,;-11.71,-2.97,;-10.8,-1.72,;-9.87,-2.78,;-11.71,-.48,;-13.17,-.95,;-14.51,-.18,;-14.51,1.36,;-9.47,-.95,;-9.47,.59,;-8.14,1.36,;-6.8,.59,;-6.8,-.95,;-8.14,-1.72,;-5.47,1.36,;-5.47,2.9,;-4.13,3.67,;-2.8,2.9,;-1.47,3.67,;-2.8,4.44,;-2.8,1.36,;-4.13,.59,)| InChI=1S/C30H42ClN3O4SSi/c1-18-15-25(39-4)23(29(36)33-18)17-32-28(35)22-16-24(31)27-26(19(22)2)37-30(3,38-27)20-7-9-21(10-8-20)34-11-13-40(5,6)14-12-34/h15-16,20-21H,7-14,17H2,1-6H3,(H,32,35)(H,33,36) DQRQLJGQFHOSPD-UHFFFAOYSA-N 636207 US20230365541, Compound 49, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.510 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636207&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551838 486501849 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351570 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)N1CC[Si](C)(C)CC1 |r,wU:29.35,wD:26.28,(5.74,-4.62,;5.74,-3.08,;4.41,-2.31,;3.07,-3.08,;1.74,-2.31,;.41,-3.08,;1.74,-.77,;3.07,,;3.07,1.54,;4.41,-.77,;5.74,,;7.07,-.77,;8.41,,;8.41,1.54,;9.74,-.77,;9.74,-2.31,;11.07,-3.08,;11.07,-4.62,;12.41,-2.31,;13.87,-2.79,;14.78,-1.54,;15.73,-2.58,;13.87,-.29,;12.41,-.77,;11.07,,;11.07,1.54,;16.11,-.77,;17.45,-1.54,;18.78,-.77,;18.78,.77,;17.45,1.54,;16.11,.77,;20.11,1.54,;20.11,3.08,;21.45,3.85,;22.78,3.08,;24.11,3.85,;22.78,4.62,;22.78,1.54,;21.45,.77,)| InChI=1S/C30H42ClN3O4SSi/c1-18-15-25(39-4)23(29(36)33-18)17-32-28(35)22-16-24(31)27-26(19(22)2)37-30(3,38-27)20-7-9-21(10-8-20)34-11-13-40(5,6)14-12-34/h15-16,20-21H,7-14,17H2,1-6H3,(H,32,35)(H,33,36) DQRQLJGQFHOSPD-UHFFFAOYSA-N 636208 US20230365541, Compound 49, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.320 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636208&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551838 486501850 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351571 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)N[C@H]1C[C@H](F)C1 |r,wU:29.35,33.36,wD:26.28,35.39,(1.04,-17.42,;1.04,-15.88,;-.3,-15.11,;-1.63,-15.88,;-2.96,-15.11,;-4.3,-15.88,;-2.96,-13.57,;-1.63,-12.8,;-1.63,-11.26,;-.3,-13.57,;1.04,-12.8,;2.37,-13.57,;3.7,-12.8,;3.7,-11.26,;5.04,-13.57,;5.04,-15.11,;6.37,-15.88,;6.37,-17.42,;7.7,-15.11,;9.17,-15.59,;10.07,-14.34,;11.41,-15.11,;9.17,-13.1,;7.7,-13.57,;6.37,-12.8,;6.37,-11.26,;11.41,-13.57,;12.74,-14.34,;14.08,-13.57,;14.08,-12.03,;12.74,-11.26,;11.41,-12.03,;15.41,-11.26,;16.74,-12.03,;18.23,-11.63,;18.63,-13.12,;19.96,-13.89,;17.14,-13.52,)| InChI=1S/C28H35ClFN3O4S/c1-14-9-23(38-4)21(27(35)32-14)13-31-26(34)20-12-22(29)25-24(15(20)2)36-28(3,37-25)16-5-7-18(8-6-16)33-19-10-17(30)11-19/h9,12,16-19,33H,5-8,10-11,13H2,1-4H3,(H,31,34)(H,32,35) SCHSLNNCDSSBLA-UHFFFAOYSA-N 636209 US20230365541, Compound 53, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.330 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636209 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636209&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551839 486501851 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351572 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@H](CN2CCOCC2)CC1 |r,wU:29.32,wD:26.28,(-5.9,-26.5,;-5.9,-24.96,;-7.23,-24.19,;-8.57,-24.96,;-9.9,-24.19,;-11.24,-24.96,;-9.9,-22.65,;-8.57,-21.88,;-8.57,-20.34,;-7.23,-22.65,;-5.9,-21.88,;-4.57,-22.65,;-3.23,-21.88,;-3.23,-20.34,;-1.9,-22.65,;-1.9,-24.19,;-.57,-24.96,;-.57,-26.5,;.77,-24.19,;2.23,-24.66,;3.14,-23.42,;4.47,-24.19,;2.23,-22.17,;.77,-22.65,;-.57,-21.88,;-.57,-20.34,;4.47,-22.65,;5.8,-23.42,;7.14,-22.65,;7.14,-21.11,;8.47,-20.34,;9.81,-21.11,;9.81,-22.65,;11.14,-23.42,;12.47,-22.65,;12.47,-21.11,;11.14,-20.34,;5.8,-20.34,;4.47,-21.11,)| InChI=1S/C29H38ClN3O5S/c1-17-13-24(39-4)22(28(35)32-17)15-31-27(34)21-14-23(30)26-25(18(21)2)37-29(3,38-26)20-7-5-19(6-8-20)16-33-9-11-36-12-10-33/h13-14,19-20H,5-12,15-16H2,1-4H3,(H,31,34)(H,32,35) STKPNEJNWCQQFQ-UHFFFAOYSA-N 636210 US20230365541, Compound 57, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.460 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636210 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636210&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551840 486501852 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351573 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@H](CN2CCOCC2)CC1 |r,wU:26.28,29.32,(-5.9,-26.5,;-5.9,-24.96,;-7.23,-24.19,;-8.57,-24.96,;-9.9,-24.19,;-11.24,-24.96,;-9.9,-22.65,;-8.57,-21.88,;-8.57,-20.34,;-7.23,-22.65,;-5.9,-21.88,;-4.57,-22.65,;-3.23,-21.88,;-3.23,-20.34,;-1.9,-22.65,;-1.9,-24.19,;-.57,-24.96,;-.57,-26.5,;.77,-24.19,;2.23,-24.66,;3.14,-23.42,;4.47,-24.19,;2.23,-22.17,;.77,-22.65,;-.57,-21.88,;-.57,-20.34,;4.47,-22.65,;5.8,-23.42,;7.14,-22.65,;7.14,-21.11,;8.47,-20.34,;9.81,-21.11,;9.81,-22.65,;11.14,-23.42,;12.47,-22.65,;12.47,-21.11,;11.14,-20.34,;5.8,-20.34,;4.47,-21.11,)| InChI=1S/C29H38ClN3O5S/c1-17-13-24(39-4)22(28(35)32-17)15-31-27(34)21-14-23(30)26-25(18(21)2)37-29(3,38-26)20-7-5-19(6-8-20)16-33-9-11-36-12-10-33/h13-14,19-20H,5-12,15-16H2,1-4H3,(H,31,34)(H,32,35) STKPNEJNWCQQFQ-UHFFFAOYSA-N 636211 US20230365541, Compound 57, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.490 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636211&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551840 486501853 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351574 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)NC1COC1 |r,wU:26.28,29.35,(14.26,6.69,;12.93,5.92,;12.93,4.38,;14.26,3.61,;14.26,2.07,;15.59,1.3,;12.93,1.3,;11.59,2.07,;10.26,1.3,;11.59,3.61,;10.26,4.38,;8.93,3.61,;7.59,4.38,;7.59,5.92,;6.26,3.61,;6.26,2.07,;4.92,1.3,;4.92,-.24,;3.59,2.07,;2.13,1.6,;1.22,2.84,;.08,3.87,;2.13,4.09,;3.59,3.61,;4.92,4.38,;4.92,5.92,;.08,1.81,;-1.39,2.29,;-2.53,1.26,;-2.21,-.25,;-.75,-.72,;.4,.31,;-3.36,-1.28,;-4.82,-.8,;-6.19,-1.5,;-6.89,-.13,;-5.52,.57,)| InChI=1S/C27H34ClN3O5S/c1-14-9-22(37-4)20(26(33)30-14)11-29-25(32)19-10-21(28)24-23(15(19)2)35-27(3,36-24)16-5-7-17(8-6-16)31-18-12-34-13-18/h9-10,16-18,31H,5-8,11-13H2,1-4H3,(H,29,32)(H,30,33) VVFAJWYHTJJBDS-UHFFFAOYSA-N 636212 7-chloro-2,4-dimethyl-N-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl-d2)-2-(4-(oxetan-3-ylamino)cyclohexyl)benzo[d][1,3]dioxole-5-carboxamide::US20230365541, Compound 59, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.570 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636212&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551841 486501854 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351575 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)NC1COC1 |r,wU:29.35,wD:26.28,(14.26,6.69,;12.93,5.92,;12.93,4.38,;14.26,3.61,;14.26,2.07,;15.59,1.3,;12.93,1.3,;11.59,2.07,;10.26,1.3,;11.59,3.61,;10.26,4.38,;8.93,3.61,;7.59,4.38,;7.59,5.92,;6.26,3.61,;6.26,2.07,;4.92,1.3,;4.92,-.24,;3.59,2.07,;2.13,1.6,;1.22,2.84,;.08,3.87,;2.13,4.09,;3.59,3.61,;4.92,4.38,;4.92,5.92,;.08,1.81,;-1.39,2.29,;-2.53,1.26,;-2.21,-.25,;-.75,-.72,;.4,.31,;-3.36,-1.28,;-4.82,-.8,;-6.19,-1.5,;-6.89,-.13,;-5.52,.57,)| InChI=1S/C27H34ClN3O5S/c1-14-9-22(37-4)20(26(33)30-14)11-29-25(32)19-10-21(28)24-23(15(19)2)35-27(3,36-24)16-5-7-17(8-6-16)31-18-12-34-13-18/h9-10,16-18,31H,5-8,11-13H2,1-4H3,(H,29,32)(H,30,33) VVFAJWYHTJJBDS-UHFFFAOYSA-N 636213 US20230365541, Compound 59, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.440 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636213&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551841 486501855 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351576 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)N1CC2COCC2C1 |r,wU:29.35,wD:26.28,(-6.03,-23.5,;-6.03,-21.96,;-7.36,-21.19,;-8.7,-21.96,;-10.03,-21.19,;-11.36,-21.96,;-10.03,-19.65,;-8.7,-18.88,;-8.7,-17.34,;-7.36,-19.65,;-6.03,-18.88,;-4.7,-19.65,;-3.36,-18.88,;-3.36,-17.34,;-2.03,-19.65,;-2.03,-21.19,;-.69,-21.96,;-.69,-23.5,;.64,-21.19,;2.1,-21.67,;3.01,-20.42,;4.34,-21.19,;2.1,-19.18,;.64,-19.65,;-.69,-18.88,;-.69,-17.34,;4.34,-19.65,;5.68,-20.42,;7.01,-19.65,;7.01,-18.11,;5.68,-17.34,;4.34,-18.11,;8.34,-17.34,;9.81,-17.82,;10.71,-16.57,;12.18,-16.09,;12.18,-14.55,;10.71,-14.08,;9.81,-15.32,;8.34,-15.8,)| InChI=1S/C30H38ClN3O5S/c1-16-9-25(40-4)23(29(36)33-16)11-32-28(35)22-10-24(31)27-26(17(22)2)38-30(3,39-27)20-5-7-21(8-6-20)34-12-18-14-37-15-19(18)13-34/h9-10,18-21H,5-8,11-15H2,1-4H3,(H,32,35)(H,33,36) ZJTAVBYSGTVJFR-UHFFFAOYSA-N 636214 US20230365541, Compound 60, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.180 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636214&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551842 486501856 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351577 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)N1CC2COCC2C1 |r,wU:26.28,29.35,(-6.03,-23.5,;-6.03,-21.96,;-7.36,-21.19,;-8.7,-21.96,;-10.03,-21.19,;-11.36,-21.96,;-10.03,-19.66,;-8.7,-18.89,;-8.7,-17.35,;-7.36,-19.66,;-6.03,-18.89,;-4.7,-19.66,;-3.36,-18.89,;-3.36,-17.35,;-2.03,-19.66,;-2.03,-21.2,;-.69,-21.97,;-.69,-23.51,;.64,-21.2,;2.1,-21.67,;3.01,-20.43,;4.34,-21.2,;2.1,-19.18,;.64,-19.66,;-.69,-18.89,;-.69,-17.35,;4.34,-19.66,;5.68,-20.42,;7.01,-19.66,;7.01,-18.12,;5.68,-17.35,;4.34,-18.12,;8.34,-17.35,;9.81,-17.82,;10.71,-16.58,;12.18,-16.1,;12.18,-14.56,;10.71,-14.08,;9.81,-15.33,;8.34,-15.81,)| InChI=1S/C30H38ClN3O5S/c1-16-9-25(40-4)23(29(36)33-16)11-32-28(35)22-10-24(31)27-26(17(22)2)38-30(3,39-27)20-5-7-21(8-6-20)34-12-18-14-37-15-19(18)13-34/h9-10,18-21H,5-8,11-15H2,1-4H3,(H,32,35)(H,33,36) ZJTAVBYSGTVJFR-UHFFFAOYSA-N 636215 US20230365541, Compound 60, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.340 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636215&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551842 486501857 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351578 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@H]1CC[C@@H](CC1)NC1COC1 |r,wU:26.28,wD:29.35,(-8.52,-6.52,;-8.52,-4.98,;-9.85,-4.21,;-11.19,-4.98,;-12.52,-4.21,;-13.85,-4.98,;-12.52,-2.67,;-11.19,-1.9,;-11.19,-.36,;-9.85,-2.67,;-8.52,-1.9,;-7.19,-2.67,;-5.85,-1.9,;-5.85,-.36,;-4.52,-2.67,;-4.52,-4.21,;-3.19,-4.98,;-3.19,-6.52,;-1.85,-4.21,;-.39,-4.68,;.52,-3.44,;1.85,-4.21,;-.39,-2.19,;-1.85,-2.67,;-3.19,-1.9,;-3.19,-.36,;1.85,-2.67,;1.85,-1.13,;3.19,-.36,;4.52,-1.13,;4.52,-2.67,;3.19,-3.44,;5.85,-.36,;7.19,-1.13,;7.59,-2.62,;9.07,-2.22,;8.67,-.73,)| InChI=1S/C27H34ClN3O5S/c1-14-9-22(37-4)20(26(33)30-14)11-29-25(32)19-10-21(28)24-23(15(19)2)35-27(3,36-24)16-5-7-17(8-6-16)31-18-12-34-13-18/h9-10,16-18,31H,5-8,11-13H2,1-4H3,(H,29,32)(H,30,33) VVFAJWYHTJJBDS-UHFFFAOYSA-N 636216 US20230365541, Compound 61, isomer 1 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.520 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636216&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551841 486501858 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6 1351579 CSc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(Cl)c2OC(C)(Oc2c1C)[C@@H]1CC[C@@H](CC1)NC1COC1 |r,wU:26.28,29.35,(-8.52,-6.52,;-8.52,-4.98,;-9.85,-4.21,;-11.19,-4.98,;-12.52,-4.21,;-13.85,-4.98,;-12.52,-2.67,;-11.19,-1.9,;-11.19,-.36,;-9.85,-2.67,;-8.52,-1.9,;-7.19,-2.67,;-5.85,-1.9,;-5.85,-.36,;-4.52,-2.67,;-4.52,-4.21,;-3.19,-4.98,;-3.19,-6.52,;-1.85,-4.21,;-.39,-4.68,;.52,-3.44,;1.85,-4.21,;-.39,-2.19,;-1.85,-2.67,;-3.19,-1.9,;-3.19,-.36,;1.85,-2.67,;3.19,-3.44,;4.52,-2.67,;4.52,-1.13,;3.19,-.36,;1.85,-1.13,;5.85,-.36,;7.19,-1.13,;7.59,-2.62,;9.07,-2.22,;8.67,-.73,)| InChI=1S/C27H34ClN3O5S/c1-14-9-22(37-4)20(26(33)30-14)11-29-25(32)19-10-21(28)24-23(15(19)2)35-27(3,36-24)16-5-7-17(8-6-16)31-18-12-34-13-18/h9-10,16-18,31H,5-8,11-13H2,1-4H3,(H,29,32)(H,30,33) VVFAJWYHTJJBDS-UHFFFAOYSA-N 636217 US20230365541, Compound 61, isomer 2 Histone-lysine N-methyltransferase EZH2 Homo sapiens 0.250 US Patent 10.7270/Q2NS102Q aid1920009 US20230365541 LI, Y; SHI, Z; ZHANG, G; WANG, W; CHEN, L; PEI, Y; YANG, L; SONG, C; TANG, P; YE, F; ZHANG, C; NI, J; YAN, P 11/16/2023 1/12/2024 Haisco Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=636217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6661&target=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=636217&enzyme=Histone-lysine+N-methyltransferase+EZH2&column=ki&startPg=0&Increment=50&submit=Search 169551841 486501859 1 MGQTGKKSEKGPVCWRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILERTEILNQEWKQRRIQPVHILTSVSSLRGTRECSVTSDLDFPTQVIPLKTLNAVASVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALGQYNDDDDDDDGDDPEEREEKQKDLEDHRDDKESRPPRKFPSDKIFEAISSMFPDKGTAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYDCFLHPFHATPNTYKRKNTETALDNKPCGPQCYQHLEGAKEFAAALTAERIKTPPKRPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDETSSSSEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIAPAPAEDVDTPPRKKKRKHRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGEIISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNGDHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP 8VNZ,8VNV,8VML,8VMI,8EQV,6WKR,6C24,6C23,5HYN,7AT8,8TB9,8TAS,8T9G,4MI0,4MI5,5U62,5U5T,7QK4,7QJU,7QJG,6LO2,5H25,5H24,5H19,5H17,5H15,5H14,5GSA,5WUK Histone-lysine N-methyltransferase EZH2 EZH2_HUMAN Q15910 B2RAQ1 B3KS30 B7Z1D6 B7Z7L6 Q15755 Q75MG3 Q92857 Q96FI6